17-75148540-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016185.4(JPT1):c.188C>T(p.Ala63Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,614,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016185.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
JPT1 | NM_016185.4 | c.188C>T | p.Ala63Val | missense_variant | 2/5 | ENST00000409753.8 | |
LOC107985034 | XR_007065907.1 | n.4731G>A | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
JPT1 | ENST00000409753.8 | c.188C>T | p.Ala63Val | missense_variant | 2/5 | 1 | NM_016185.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251444Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135902
GnomAD4 exome AF: 0.000131 AC: 192AN: 1461866Hom.: 0 Cov.: 31 AF XY: 0.000149 AC XY: 108AN XY: 727234
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 01, 2023 | The c.188C>T (p.A63V) alteration is located in exon 2 (coding exon 2) of the HN1 gene. This alteration results from a C to T substitution at nucleotide position 188, causing the alanine (A) at amino acid position 63 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at